The private company data space is vast, fragmented, and often overwhelming. Deal sourcing teams are faced with endless streams of announcements, filings, atSnd rumors, making it difficult to pinpoint the transactions that actually matter.
That’s why inside Dakota Marketplace, we’ve zeroed in on this space. We’ve created a centralized resource where deal sourcers can easily find and track the exact deals they’re looking for.
In this article, we’ve curated 10 top transactions from last week that stood out in the marketplace and signal key trends shaping the deal landscape. By the end of this, you’ll have a better understanding of these deals.
- Transaction Date: 1/21/2026
- Type: Acquisition/Merger
- Sector: Financials
- Transaction Value: $6.2B
- Participants: Deutsche Boerse AG
Deutsche Börse Group has agreed to acquire Allfunds Group in a recommended transaction valuing Allfunds at approximately €5.3 billion, offering shareholders €8.80 per share through a mix of cash, Deutsche Börse shares, and dividends. The deal, unanimously supported by Allfunds’ board and major shareholders, aims to create a global fund services leader by combining Allfunds’ distribution platform with Deutsche Börse’s Clearstream capabilities, with completion expected in the first half of 2027.
- Transaction Date: 1/22/2026
- Type: Acquisition/Merger
- Sector: Financials
- Transaction Value: $5.15B
- Participants: Capital One
Capital One has agreed to acquire Brex in a stock-and-cash transaction valued at $5.15 billion, strengthening its position in business payments by adding Brex’s AI-native corporate card, spend management, and payments platform. The deal, which keeps Brex CEO Pedro Franceschi leading the business, is expected to close in mid-2026 pending customary approvals.
- Transaction Date: 1/22/2026
- Type: Acquisition/Merger
- Sector: Communication Services
- Transaction Value: $3.91B
- Participants: Arise Digital
Telenor has agreed to sell its 24.95% stake in True Corporation to Arise Digital Technology for approximately NOK 39 billion, with an additional put/call option to divest its remaining 5.35% stake two years after closing. The transaction marks Telenor’s exit from Thailand after 25 years and supports its strategy to simplify operations and refocus capital toward core Nordic markets.
- Transaction Date: 1/22/2026
- Type: Acquisition/Merger
- Sector: Financials
- Transaction Value: $3.2B
- Participants: EQT
EQT has agreed to acquire Coller Capital in a predominantly share-based transaction valued at a base consideration of $3.2 billion, creating a new secondaries platform branded “Coller EQT” and marking EQT’s entry into the fast-growing private markets secondaries space. The combination brings together EQT’s global multi-asset platform with Coller’s specialist secondaries expertise and is expected to close in Q3 2026, subject to regulatory and investor approvals.
- Transaction Date: 1/22/2026
- Type: Acquisition/Merger
- Sector: Consumer Staples
- Transaction Value: $2.25B
- Participants: Clorox
Clorox has agreed to acquire GOJO Industries, the maker of Purell®, for $2.25 billion in cash, expanding its health and hygiene portfolio to include skin hygiene across both consumer and professional markets. The deal strengthens Clorox’s Health and Wellness segment, is expected to be accretive to growth and earnings over time, and is slated to close before the end of fiscal year 2026, subject to regulatory approval.
- Transaction Date: 1/20/2026
- Type: Acquisition/Merger
- Sector: Health Care
- Transaction Value: $2.2B
- Participants: GSK
GSK has agreed to acquire RAPT Therapeutics for $58.00 per share in cash, valuing the company at approximately $2.2 billion, to strengthen its pipeline in inflammatory and immunologic diseases. The deal adds ozureprubart, a long-acting anti-IgE antibody in Phase IIb development for food allergy, and is expected to close in the first quarter of 2026.
- Transaction Date: 1/20/2026
- Type: Acquisition/Merger
- Sector: Health Care
- Transaction Value: $2.125B
- Participants: Shionogi
GSK and Shionogi have agreed to replace Pfizer’s 11.7% stake in ViiV Healthcare with a $2.125 billion investment from Shionogi, increasing Shionogi’s ownership to 21.7% while GSK retains a 78.3% majority stake. The transaction simplifies ViiV Healthcare’s shareholder structure, provides Pfizer with $1.875 billion in proceeds, and is expected to close in the first quarter of 2026, subject to regulatory approvals.
- Transaction Date: 1/23/2026
- Type: Buyout/Private Equity
- Sector: Consumer Discretionary
- Transaction Value: $1.4B
- Participants: Authentic Brands
Authentic Brands Group and Guess? co-founders Maurice and Paul Marciano have completed a transaction to take Guess? private, with Authentic acquiring 51% of the brand’s intellectual property and the remaining 49% held by the Marciano-led rolling shareholders, while current management retains full ownership of the operating company. The deal, which valued Guess? at approximately $1.4 billion, positions Guess? as Authentic’s second-largest brand and provides greater flexibility to accelerate global brand growth under private ownership.
- Transaction Date: 1/21/2026
- Type: Credit
- Sector: Information Technology
- Transaction Value: $1.2B
- Participants: MMC Ventures, QED Investors, EIF
Cloover has secured a combined $1.222 billion financing package, consisting of a $22 million Series A equity round and a $1.2 billion debt facility, to scale its AI-powered operating system for decentralized energy. The capital will support platform expansion across Europe, embedded financing for installers and households, and accelerated deployment of residential energy independence solutions.
- Transaction Date: 1/18/2026
- Type: Acquisition/Merger
- Sector: Health Care
- Transaction Value: $630M
- Participants: AstraZeneca
AstraZeneca has agreed to acquire AbelZeta’s remaining 50% China rights to the GPC3-targeting CAR-T therapy C-CAR031, securing full global development, manufacturing, and commercialization control of the program. AbelZeta is eligible to receive up to $630 million in upfront and milestone payments, reflecting AstraZeneca’s commitment to advancing the therapy for hepatocellular carcinoma and other solid tumors.
Transactions with Dakota Marketplace
At Dakota, we understand how important it is to stay current on deal activity as it happens. That’s why our editorial team is constantly monitoring the news for real-time updates on platform investments, add-ons, divestitures, and more. Each day, we deliver these highlights directly to your inbox through our transactions newsletter.
Inside Dakota Marketplace, the transactions tab gives you access to structured, filterable data complete with dates, deal structure, sectors, and financials, so you can build a feed tailored to your specific interests.
Whether you're evaluating a new investment opportunity or tracking trends in a target sector or segment, Dakota Marketplace helps you cut through the noise and focus on what matters most.
For more information on these transactions and a deeper dive into their industries and sub-industries, book a demo of Dakota Marketplace.
